Corrigendum to “cadmium Physiologically Based Pharmacokinetic (PBPK) Models for Forward and Reverse Dosimetry: Review, Evaluation, and Adaptation to the U.S. Population” [toxicol. Lett. 367 (2022) 67–75] | AMiner
Corrigendum to “cadmium Physiologically Based Pharmacokinetic (PBPK) Models for Forward and Reverse Dosimetry: Review, Evaluation, and Adaptation to the U.S. Population” [toxicol. Lett. 367 (2022) 67–75]